Newron Pharmaceuticals SpA's total assets for Q4 2025 were €40.02M, a decrease of -34.81% from the previous quarter. CH:NWRN total liabilities were €51.15M for the fiscal quarter, a -14.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.